Literature DB >> 8121570

The limited value of cytoreductive surgery in elderly patients with malignant gliomas.

P J Kelly1, C Hunt.   

Abstract

In this retrospective, consecutive series of 128 elderly patients (over 65 years of age) with histologically proven Grade 4 astrocytomas, 88 patients underwent stereotactic biopsy and 40 patients underwent stereotactic volumetric resection of the mass lesion defined by contrast enhancement on computed tomography. There were no significant differences in age (average age in the biopsy group, 71.6 yr; resection group, 70.15 yr) or Karnofsky Performance Scores (biopsy group, 84.33; resection group, 83.88) between the two groups. Four of the biopsy patients and one of the resection patients died within 30 days of surgery. The overall mean survival was 126 days; 108 days (15.4 wk) in the patients who had biopsies and 189 days (27 wk) in the patients who had resections. Radiation therapy was completed in 62 of the patients who had biopsies (mean survival, 118 d or 16.9 wk) and 34 of the patients undergoing resection (mean survival, 210 d or 30 wk) (log rank P = 0.0215; Smirnov P = 0.006). Although some prolongation of survival is noted after resection (more than after a biopsy) in selected patients over 65 years of age, that benefit is modest.

Entities:  

Mesh:

Year:  1994        PMID: 8121570

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  31 in total

Review 1.  The role of image-guided technology in the surgical planning and resection of gliomas.

Authors:  G H Barnett
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 2.  Extent of resection as a prognostic variable in the treatment of gliomas.

Authors:  K R Hess
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA.

Authors:  Walter Stummer; Ulf Nestler; Florian Stockhammer; Dietmar Krex; Bodo C Kern; Hubert M Mehdorn; Giles H Vince; Uwe Pichlmeier
Journal:  J Neurooncol       Date:  2010-10-05       Impact factor: 4.130

4.  Biopsy versus resection in the management of high-grade gliomas in the elderly.

Authors:  Yingjie Zou; Harrison Xiao Bai; Zhili Wang; Li Yang
Journal:  Neuro Oncol       Date:  2015-03-10       Impact factor: 12.300

5.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

6.  Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery.

Authors:  Timothy C Ryken; Bruce Frankel; Terrance Julien; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

7.  [Value of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature].

Authors:  M van Kampen; R Engenhart-Cabillic; J Debus; M Fuss; B Rhein; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

8.  Long-term follow-up results of 175 patients with malignant glioma.

Authors:  F W Kreth; P C Warnke; C B Ostertag
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision.

Authors:  Stephanie G Kellermann; Christina A Hamisch; Daniel Rueß; Tobias Blau; Roland Goldbrunner; Harald Treuer; Stefan J Grau; Maximilian I Ruge
Journal:  J Neurooncol       Date:  2017-06-21       Impact factor: 4.130

Review 10.  Treating glioblastoma in the elderly.

Authors:  Jaime Gállego Pérez-Larraya; Jean-Yves Delattre
Journal:  CNS Oncol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.